Haris Omić, Farsad Eskandary, Dietrich Beitzke, Marcos Wolf, Nicolas Kozakowski, Georg Böhmig, Andrea Beck-Tölly, Michael Eder
{"title":"T<sub>1</sub> Relaxation Time for the Prediction of Renal Transplant Dysfunction.","authors":"Haris Omić, Farsad Eskandary, Dietrich Beitzke, Marcos Wolf, Nicolas Kozakowski, Georg Böhmig, Andrea Beck-Tölly, Michael Eder","doi":"10.3389/ti.2025.14301","DOIUrl":null,"url":null,"abstract":"<p><p>Quantitative magnetic resonance imaging (MRI) is emerging as a non-invasive tool to measure tissue scarring in renal allografts. However, whether prolonged T<sub>1</sub> relaxation time results in lower transplant survival rates is unknown. This retrospective cohort study analyzed the capability to predict renal allograft dysfunction based on median T<sub>1</sub> time. Forty-six transplant recipients with non-contrast 1.5T MRI and allograft biopsy were included. The primary endpoint was the eGFR slope over 24 months. T<sub>1</sub> relaxation time correlated significantly with eGFR levels at all follow-up stages. Patients with T<sub>1</sub> relaxation time above the median (T<sub>1</sub> <sup>high</sup>) had a consistent decline in kidney function as compared to the patient group below the median (T<sub>1</sub> <sup>low</sup>): overall eGFR slope: 11.3 vs. 1.4 mL/min/1.73 m<sup>2</sup> over 24 months, p = 0.016. Graft survival rates at 24 months were 52% in the T<sub>1</sub> <sup>high</sup> vs. 87% in the T<sub>1</sub> <sup>low</sup> group, p = 0.0015. ROC analysis discovered a positive predictive value of 52% and a negative predictive value of 91% for graft loss. T<sub>1</sub> mapping identified patients with a persistent decline of allograft function and an increased risk of allograft loss. MRI could significantly influence monitoring strategies in transplant surveillance, offering a safe, non-invasive alternative to traditional diagnostic methods.</p>","PeriodicalId":23343,"journal":{"name":"Transplant International","volume":"38 ","pages":"14301"},"PeriodicalIF":2.7000,"publicationDate":"2025-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12018245/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transplant International","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/ti.2025.14301","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
Quantitative magnetic resonance imaging (MRI) is emerging as a non-invasive tool to measure tissue scarring in renal allografts. However, whether prolonged T1 relaxation time results in lower transplant survival rates is unknown. This retrospective cohort study analyzed the capability to predict renal allograft dysfunction based on median T1 time. Forty-six transplant recipients with non-contrast 1.5T MRI and allograft biopsy were included. The primary endpoint was the eGFR slope over 24 months. T1 relaxation time correlated significantly with eGFR levels at all follow-up stages. Patients with T1 relaxation time above the median (T1high) had a consistent decline in kidney function as compared to the patient group below the median (T1low): overall eGFR slope: 11.3 vs. 1.4 mL/min/1.73 m2 over 24 months, p = 0.016. Graft survival rates at 24 months were 52% in the T1high vs. 87% in the T1low group, p = 0.0015. ROC analysis discovered a positive predictive value of 52% and a negative predictive value of 91% for graft loss. T1 mapping identified patients with a persistent decline of allograft function and an increased risk of allograft loss. MRI could significantly influence monitoring strategies in transplant surveillance, offering a safe, non-invasive alternative to traditional diagnostic methods.
期刊介绍:
The aim of the journal is to serve as a forum for the exchange of scientific information in the form of original and high quality papers in the field of transplantation. Clinical and experimental studies, as well as editorials, letters to the editors, and, occasionally, reviews on the biology, physiology, and immunology of transplantation of tissues and organs, are published. Publishing time for the latter is approximately six months, provided major revisions are not needed. The journal is published in yearly volumes, each volume containing twelve issues. Papers submitted to the journal are subject to peer review.